Approval · Notice of Compliance 3933 · 1997
LARIAM: Notice of Compliance 3933
Issued December 18, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3933
- Date
- December 18, 1997
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for product monograph revisions: - modifications to the current mefloquine treatment recommendations for children - mefloquine loading dose option for malaria prophylaxis
- Therapeutic class
- Antimalarial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LARIAM | Not yet assigned | — |
Medicinal ingredients
- MEFLOQUINE HCL 250 MG per TAB